StockCIK 1061983
CYTOKINETICS INC (CYTK): Insider Trades and Fund Holdings
In the past 12 months, CYTOKINETICS INC insiders reported 0 open-market purchases worth $0 and 14 sales worth $11.2M; 14 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$11.2MSold by insiders, 12 months
0Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 20, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 20 | Fady Ibraham MalikEVP | ▼ SELL10b5-1 | $224K |
| Oct 13 | Robert I. BlumCEO | ▼ SELL10b5-1 | $472K |
| Oct 6 | Fady Ibraham MalikEVP | ▼ SELL10b5-1 | $215K |
| Sep 28 | Robert I. BlumCEO | ▼ SELL10b5-1 | $491K |
| Sep 22 | Fady Ibraham MalikEVP | ▼ SELL10b5-1 | $239K |
| Sep 15 | Robert I. BlumCEO | ▼ SELL10b5-1 | $6.79M |
| Sep 15 | Robert I. BlumCEO | ▼ SELL10b5-1 | $551K |
| Sep 15 | Robert E. LandryDirector | ▼ SELL10b5-1 | $72K |
| Sep 11 | Robert E. LandryDirector | ▼ SELL10b5-1 | $75K |
| Sep 8 | Fady Ibraham MalikEVP | ▼ SELL10b5-1 | $264K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 14 CYTK insider trades →Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Fady Ibraham Malik | EVP | 0 | $0 | 5 | $1.21M |
| Robert I. Blum | CEO | 0 | $0 | 5 | $8.83M |
| Robert E. Landry | Director | 0 | $0 | 2 | $147K |
| B. Lynne Parshall | Director | 0 | $0 | 1 | $357K |
| Andrew Callos | EVP | 0 | $0 | 1 | $702K |
ADVERTISEMENT
320 × 100 ad slot
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →